
Download Files:
7BIO
SKU
HY-121035-1 mg
Category Reference compound
Tags CDK;GSK-3, Cell Cycle/DNA Damage;PI3K/Akt/mTOR;Stem Cell/Wnt, Neurological Disease
$38 – $600
Products Details
Product Description
– 7BIO (7-Bromoindirubin-3-Oxime) is the derivate of indirubin. 7BIO (7-Bromoindirubin-3-Oxime) has inhibitory effects against cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3β (GSK3β). 7BIO (7-Bromoindirubin-3-Oxime) inhibits Aβ oligomer-induced neuroinflammation, synaptic impairments, tau hyper-phosphorylation, activation of astrocytes and microglia, and attenuates Aβ oligomer-induced cognitive impairments in mice[1].
Web ID
– HY-121035
Storage Temperature
– 4°C (Powder, protect from light)
Shipping
– Room Temperature
Applications
– Neuroscience-Neurodegeneration
Molecular Formula
– C16H10BrN3O2
References
– [1] Chen L, et al. Indirubin Derivative 7-Bromoindirubin-3-Oxime (7Bio) Attenuates Aβ Oligomer-Induced Cognitive Impairments in Mice. Front Mol Neurosci. 2017;10:393.
CAS Number
– 916440-85-2
Molecular Weight
– 356.17
Compound Purity
– 98.0
SMILES
– O/N=C1C2=CC=CC=C2NC1=C3C(NC4=C(C=CC=C4/3)Br)=O
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– DMSO : 250 mg/mL (ultrasonic)|Ethanol : 50 mg/mL (ultrasonic)
Target
– CDK;GSK-3
Isoform
– CDK5;GSK-3β
Pathway
– Cell Cycle/DNA Damage;PI3K/Akt/mTOR;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.